AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...

As temperatures drop, many people experience dry, red, and itchy skin, a condition that often worsens in winter.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Ruxolitinib cream 1.5% was safe and effective for the treatment of children and adolescents with a 35% or greater body surface areas affected by atopic dermatitis, according to a study.Ruxolitinib ...

Researchers studied genetically modified mice that lack NP2 itch-sensing neurons, to investigate the connection between itch, ...

Jonathan Wolleben, an analyst from JMP Securities, has initiated a new Buy rating on Astria Therapeutics (ATXS).Invest with Confidence: Follow ...

Long-term lebrikizumab was effective for atopic dermatitis treatment in patients who did not have adequate response to short-term treatment.

Newly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, compares clinical outcomes ...

2. Recognize etiologic factors that may cause or exacerbate perioral dermatitis. 3. Choose appropriate treatments for perioral dermatitis in children and adults, including challenging cases.

Constantly scratching and picking at an itchy rash really does make it worse. But why? According to newly released research ...

The following is a summary of “A year in review: new treatments and expanded indications in dermatology in 2024,” published in the January 2025 issue of Dermatology by McGrath et al. In 2024, ...